A COVID-19 remembrance project, two videos, an article about bad brain cells and Stanford Medicine magazine have been recognized by the Council for Advancement and Support of Education.

The American Heart Association has provided funding to two Stanford Medicine professors to develop ways to diversify enrollment in heart disease clinical trials.

Children as young as 6 months can now receive the Pfizer BioNTech and Moderna mRNA vaccines.

Using a method they developed for stem cell transplants, a Stanford team has enabled children with immune disorders to receive a new immune system and a matching kidney from a parent.

The funding, from Cancer Grand Challenges, will help the researchers address difficult problems in cancer prevention, treatment-resistant cancers and therapies for pediatric solid tumors.

Stanford Medicine researchers and their collaborators have identified a molecule that staves off hunger post-exercise.

Stanford Medicine’s SyneRx will develop drugs to fight viral pathogens with high pandemic potential, including the one that causes COVID-19.

Using machine learning, researchers from Stanford Medicine and their collaborators found specific genetic signals in people who develop severe coronavirus infection.

Researchers found that damage to the brain’s white matter after COVID-19 resembles that seen after cancer chemotherapy, raising hope for treatments to help both conditions.

Doctoral, medical and physician assistant students hear messages of hope and compassion as they celebrate graduation.

More than 40 awards were given to faculty, staff, residents and students at Stanford Medicine in recognition of their outstanding contributions during the 2021-2022 academic year.

The monkeypox virus is normally endemic to Africa but has recently been found on other continents. It spreads through prolonged, direct contact with infected people or their bedding, clothing and towels.